Joel C Bronstein

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi request reprint 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms
    Edmund L Ellsworth
    Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
    J Med Chem 49:6435-8. 2006
  2. pmc Purification and characterization of recombinant Staphylococcus haemolyticus DNA gyrase and topoisomerase IV expressed in Escherichia coli
    Joel C Bronstein
    Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
    Antimicrob Agents Chemother 48:2708-11. 2004

Detail Information

Publications2

  1. ncbi request reprint 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms
    Edmund L Ellsworth
    Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
    J Med Chem 49:6435-8. 2006
    ..These agents also demonstrate in vivo efficacy in murine systemic infection models...
  2. pmc Purification and characterization of recombinant Staphylococcus haemolyticus DNA gyrase and topoisomerase IV expressed in Escherichia coli
    Joel C Bronstein
    Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
    Antimicrob Agents Chemother 48:2708-11. 2004
    ..This represents the first description of a method for isolating type II topoisomerases of a coagulase-negative staphylococcal species...